Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive pulmonary disease (COPD). It contains an inhaled corticosteroid called ...
Companies like AstraZeneca and GSK, which have high-revenue-generating inhalers for asthma and chronic obstructive ... AstraZeneca’s Symbicort inhaler accounts for most of its inhalation ...
A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy. The phase 3b BATURA study showed Airsupra ...